您的位置: 首页 > 农业专利 > 详情页

PD-1 and CTLA-4 dual inhibitor peptides
专利权人:
Inc.;Leidos
发明人:
Gutierrez, Gabriel M.,Kotraiah, Vinayaka,Phares, Timothy,Pannucci, James
申请号:
AU2018273958
公开号:
AU2018273958A1
申请日:
2018.05.25
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
This disclosure provides peptides which have a strong affinity for the checkpoint receptor "programmed death 1" (PD-1). These peptides block the interaction of PD-1 with its ligand PD-L1 as well as the interaction of CTLA4 with CD86 and can therefore be used for various therapeutic purposes, such as inhibiting the progression of a hyperproliferative disorder, including cancer; treating infectious diseases; enhancing a response to vaccination; treating sepsis; and promoting hair re-pigmentation or lightening of pigmented skin lesions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充